Skip to main content
. Author manuscript; available in PMC: 2020 Jul 8.
Published in final edited form as: Lancet Respir Med. 2018 Jun;6(6):472–478. doi: 10.1016/S2213-2600(18)30172-3

Figure 1: Clinical manifestations of immune checkpoint related pulmonary toxicity.

Figure 1:

Symptoms might include dyspnoea, chest discomfort, cough, hypoxia, or, less commonly, fever. Differential diagnosis includes disease -related complaints or other treatment-related complications such as infection or anaemia.